ESB
AGN

Essex Savings Bank’s Allergan plc AGN Stock Holding History

Essex Savings Bank’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-645
Closed -$108K – 673
2019
Q2 		$108K Buy
645
+478
+286% +$66.2K 0.04% 331
2019
Q1 		$24K Hold
167
– – 0.01% 398
2018
Q4 		$22K Buy
+167
New +$27.4K 0.01% 396

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Essex Savings Bank's AGN Position: Q3 2019 in Review

Essex Savings Bank sold out of Allergan plc (AGN) in Q3 2019, closing a stake of 645 shares — an estimated $108K sold.

Essex Savings Bank first reported a position in AGN in Q4 2018 and held it in 3 quarters. The position peaked at $108K in Q2 2019. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

  • Essex Savings Bank reported no remaining Allergan plc position as of Q3 2019 after selling out during the quarter.
  • Essex Savings Bank sold 645 Allergan plc shares in Q3 2019, an estimated $108K.
  • Essex Savings Bank first reported a position in Allergan plc in Q4 2018 and held it in 3 quarters.
  • Essex Savings Bank's Allergan plc position peaked at $108K in Q2 2019.
  • 921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on Essex Savings Bank's 13F filing for Q3 2019, filed 30 Oct 2019.